As of 2026-04-04, the EV/EBITDA ratio of HOOKIPA Pharma Inc (HOOK) is 0.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HOOK's latest enterprise value is -26.96 mil USD. HOOK's TTM EBITDA according to its financial statements is -67.99 mil USD. Dividing these 2 quantities gives us the above HOOK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 14.6x | 14.3x |
| Forward P/E multiples | 15.7x - 20.1x | 18.0x |
| Fair Price | (55.21) - 4.99 | (27.03) |
| Upside | -6669.8% - 494.3% | -3317.2% |
| Date | EV/EBITDA |
| 2026-03-31 | 0.35 |
| 2026-03-30 | 0.35 |
| 2026-03-27 | 0.35 |
| 2026-03-26 | 0.34 |
| 2026-03-25 | 0.34 |
| 2026-03-24 | 0.34 |
| 2026-03-23 | 0.34 |
| 2026-03-20 | 0.35 |
| 2026-03-18 | 0.34 |
| 2026-03-17 | 0.34 |
| 2026-03-16 | 0.34 |
| 2026-03-13 | 0.34 |
| 2026-03-11 | 0.35 |
| 2026-03-10 | 0.35 |
| 2026-03-09 | 0.35 |
| 2026-03-06 | 0.35 |
| 2026-03-05 | 0.35 |
| 2026-03-04 | 0.35 |
| 2026-03-03 | 0.35 |
| 2026-03-02 | 0.35 |
| 2026-02-27 | 0.35 |
| 2026-02-26 | 0.35 |
| 2026-02-25 | 0.35 |
| 2026-02-24 | 0.36 |
| 2026-02-23 | 0.36 |
| 2026-02-20 | 0.36 |
| 2026-02-19 | 0.35 |
| 2026-02-18 | 0.35 |
| 2026-02-17 | 0.35 |
| 2026-02-13 | 0.36 |
| 2026-02-12 | 0.35 |
| 2026-02-11 | 0.35 |
| 2026-02-10 | 0.35 |
| 2026-02-09 | 0.35 |
| 2026-02-06 | 0.35 |
| 2026-02-05 | 0.35 |
| 2026-02-04 | 0.35 |
| 2026-02-03 | 0.35 |
| 2026-02-02 | 0.36 |
| 2026-01-30 | 0.36 |
| 2026-01-29 | 0.36 |
| 2026-01-28 | 0.36 |
| 2026-01-27 | 0.36 |
| 2026-01-26 | 0.36 |
| 2026-01-23 | 0.36 |
| 2026-01-22 | 0.36 |
| 2026-01-21 | 0.36 |
| 2026-01-20 | 0.36 |
| 2026-01-16 | 0.37 |
| 2026-01-15 | 0.37 |